Insider trading

Period: 120 months Stock: NTLA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

152 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

152 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

152 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

152 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
152 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
152 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

152 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Oct 2026
Dube Michael P VP, Chief Accounting Officer
Sold at will
$23.17K 1,864 at 12.43
2.8%
Not planned
21 Aug 2026
LEONARD JOHN M President and CEO
Sold on a plan
$36.21K 2,785 at 13.00
0.2%
Planned (10b5-1)
20 Aug 2026
LEONARD JOHN M President and CEO
Sold on a plan
$250.61K 19,890 at 12.60
1.7%
Planned (10b5-1)
22 Jul 2026
Dulac Edward J III EVP, Chief Financial Officer
Sold at will
$91.25K 8,111 at 11.25
5.2%
Not planned
2 Jul 2026
Dulac Edward J III EVP, Chief Financial Officer
Sold on a plan
$84.19K 4,677 at 18.00
2.9%
Planned (10b5-1)
1 Jul 2026
Dube Michael P VP, Chief Accounting Officer
Sold at will
$44.32K 2,641 at 16.78
3.8%
Not planned
2 Mar 2026
BASTA JAMES EVP, General Counsel
Sold at will
$16.69K 1,211 at 13.78
0.8%
Not planned
2 Mar 2026
Clark Eliana EVP, Chief Technical Officer
Sold at will
$8.36K 607 at 13.78
0.6%
Not planned
5 Jan 2026
Cohen Fred E Director
Bought
$1.40M 150,000 at 9.35
261%
First buy on file
5 Jan 2026
LEONARD JOHN M President and CEO
Sold at will
$314.48K 34,146 at 9.21
3.3%
Not planned
5 Jan 2026
Lebwohl David EVP, Chief Medical Officer
Sold at will
$109.63K 11,903 at 9.21
8.9%
Not planned
5 Jan 2026
BASTA JAMES EVP, General Counsel
Sold at will
$95.76K 10,397 at 9.21
9.3%
Not planned
5 Jan 2026
Clark Eliana EVP, Chief Technical Officer
Sold at will
$87.63K 9,515 at 9.21
9.8%
Not planned
5 Jan 2026
Schultes Birgit C EVP, Chief Scientific Officer
Sold at will
$78.36K 8,508 at 9.21
7.9%
Not planned
5 Jan 2026
Dulac Edward J III EVP, Chief Financial Officer
Sold at will
$58.75K 6,379 at 9.21
6.0%
Not planned
5 Jan 2026
Dube Michael P VP, Chief Accounting Officer
Sold at will
$27.53K 2,989 at 9.21
5.4%
Not planned
11 Dec 2025
LEONARD JOHN M President and CEO
Sold on a plan 3×
$836.38K 88,146 at 9.49
7.8%
Planned (10b5-1)
1 Oct 2025
Dube Michael P VP, Chief Accounting Officer
Sold at will
$32.52K 1,871 at 17.38
3.3%
Not planned
1 Oct 2025
Schultes Birgit C EVP, Chief Scientific Officer
Sold at will
$538.78 31 at 17.38
0.0%
Not planned
20 Aug 2025
CHASE WILLIAM J Director
Bought
$1.00M 100,000 at 10.03
288%
First buy on file
23 Jul 2025
Dulac Edward J III EVP, Chief Financial Officer
Sold at will
$104.62K 7,462 at 14.02
6.6%
Not planned
2 Jul 2025
Dube Michael P VP, Chief Accounting Officer
Sold at will
$24.90K 2,503 at 9.95
4.2%
Not planned
1 Jul 2025
GOODMAN JESSE Director
Sold on a plan
$14.28K 1,547 at 9.23
6.0%
Planned (10b5-1)
1 Jul 2025
Clark Eliana EVP, Chief Technical Officer
Sold at will
$10.04K 1,022 at 9.82
1.1%
Not planned
30 Jun 2025
GOODMAN JESSE Director
Sold on a plan
$14.79K 1,547 at 9.56
5.6%
Planned (10b5-1)
29 Apr 2025
Bhanji Muna Director
Sold on a plan
$2.25K 265 at 8.50
1.4%
Planned (10b5-1)
4 Mar 2025
BASTA JAMES EVP, General Counsel
Sold at will
$23.12K 2,572 at 8.99
2.2%
Not planned
4 Mar 2025
Clark Eliana EVP, Chief Technical Officer
Sold at will
$6.10K 679 at 8.99
0.7%
Not planned
29 Jan 2025
Bhanji Muna Director
Sold on a plan
$2.64K 265 at 9.97
1.3%
Planned (10b5-1)
3 Jan 2025
LEONARD JOHN M President and CEO
Sold at will
$326.51K 26,807 at 12.18
2.8%
Not planned
3 Jan 2025
Lebwohl David EVP, Chief Medical Officer
Sold at will
$116.40K 9,557 at 12.18
9.8%
Not planned
3 Jan 2025
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold at will
$109.21K 8,966 at 12.18
10.4%
Not planned
3 Jan 2025
Clark Eliana EVP, Chief Technical Officer
Sold at will
$90.40K 7,422 at 12.18
10.4%
Not planned
3 Jan 2025
BASTA JAMES EVP, General Counsel
Sold at will
$86.16K 7,074 at 12.18
8.7%
Not planned
3 Jan 2025
Hicks Derek EVP, Chief Business Officer
Sold at will
$79.19K 6,502 at 12.18
9.8%
Not planned
3 Jan 2025
Dube Michael P VP, Chief Accounting Officer
Sold at will
$16.71K 1,372 at 12.18
2.9%
Not planned
2 Jan 2025
Clark Eliana EVP, Chief Technical Officer
Sold at will
$6.69K 556 at 12.03
0.8%
Not planned
2 Oct 2024
Dube Michael P VP, Chief Accounting Officer
Sold at will
$38.25K 2,012 at 19.01
4.1%
Not planned
1 Jul 2024
Clark Eliana EVP, Chief Technical Officer
Sold at will
$9.29K 405 at 22.93
0.6%
Not planned
17 Jun 2024
Verwiel Frank Director
Sold on a plan
$37.63K 1,505 at 25.00
7.7%
Planned (10b5-1)
4 Mar 2024
BASTA JAMES EVP, General Counsel
Sold at will
$75.78K 2,297 at 32.99
2.7%
Not planned
4 Mar 2024
Clark Eliana EVP, Chief Technical Officer
Sold at will
$19.96K 605 at 32.99
0.8%
Not planned
8 Jan 2024
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold on a plan 2×
$65.68K 2,275 at 28.87
4.9%
Planned (10b5-1)
3 Jan 2024
LEONARD JOHN M President and CEO
Sold at will
$566.31K 19,223 at 29.46
2.2%
Not planned
3 Jan 2024
Lebwohl David EVP, Chief Medical Officer
Sold at will
$172.13K 5,843 at 29.46
9.7%
Not planned
3 Jan 2024
Sepp-Lorenzino Laura EVP, Chief Scientific Officer
Sold at will
$162.97K 5,532 at 29.46
10.7%
Not planned
3 Jan 2024
Goddard Glenn EVP, Chief Financial Officer
Sold at will
$158.05K 5,365 at 29.46
11.7%
Not planned
3 Jan 2024
Clark Eliana EVP, Chief Technical Officer
Sold at will 2×
$135.95K 4,608 at 29.50
10.1%
Not planned
3 Jan 2024
Hicks Derek EVP, Chief Business Officer
Sold at will
$114.22K 3,877 at 29.46
9.5%
Not planned
3 Jan 2024
BASTA JAMES EVP, General Counsel
Sold at will
$112.10K 3,805 at 29.46
6.9%
Not planned
Showing 1–50 of 152. Page 1 of 4 Older →